Feasibility and Safety of In-bed Self-exercise in Patients With Subacute Stroke
Protocol for a Single-blind Randomized Controlled Clinical Trial to Investigate the Feasibility and Safety of In-bed Self-exercise Based on Electromyography Sensor Feedback in Patients With Subacute Stroke
2 other identifiers
interventional
24
1 country
1
Brief Summary
The goal of this to investigate the feasibility and safety of in-bed self-exercises based on EMG-sensor feedback in subacute stroke patients. The main question is feasibility and safety. It aims to answer are: \[Pittsburgh Rehabilitation Participation Scale\] \[The number and percentage of participating sessions\] \[The number and percentage of completed sessions\] \[The number and percentage of successful sessions\] \[The mean amplitude of muscle contractions in a session\] \[The duration and percentage of participating sessions during self-exercise\] \[Rivermead motor assessment\] \[Manual muscle test\] \[brunnstrom stages of motor recovery\] \[Fugl Meyer assessment of lower extremity\] \[Berg balance scale\] \[Functional ambulation category\] \[modified Rankin scale\] \[modified Barthel index\] \[Short-form Health Survery 36 version 2\]
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable stroke
Started Oct 2023
Typical duration for not_applicable stroke
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 23, 2023
CompletedFirst Posted
Study publicly available on registry
April 20, 2023
CompletedStudy Start
First participant enrolled
October 25, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 25, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2026
ExpectedJune 2, 2025
May 1, 2025
1.4 years
March 23, 2023
May 30, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Change of Pittsburgh Rehabilitation Participation Scale
The PRPS is a clinician-assessed instrument designed to assess patient participation in treatment. It is rated on a scale of 1 to 6 to measure the patient's effort and activeness to participate in treatment. Score '6' if the patient participated in all exercises and ' 1' if the patient refused the entire session. The PRPS had high interrater reliability(ICC=.96).
baseline-3weeks
Secondary Outcomes (14)
Change of The number and percentage of participating sessions
baseline-3weeks
Change of The number and percentage of completed sessions
baseline-3weeks
Change of The number and percentage of successful sessions
baseline-3weeks
Change of The mean amplitude of muscle contractions in a session
baseline-3weeks
The duration and percentage of participating sessions during self-exercise
baseline-3weeks
- +9 more secondary outcomes
Study Arms (2)
in-bed self-exercises based on EMG-sensor feedback intervention
EXPERIMENTALConventional rehabilitation corresponds to general rehabilitation for lower extremity motor function in stroke patients and is mainly performed according to functional mobility with a range of motion. This includes lying down, standing, walking, and balance training. Additional in-bed self-exercises based on EMG-sensor feedback with conventional rehabilitation.
Conventional rehabilitation
NO INTERVENTIONConventional rehabilitation corresponds to general rehabilitation for lower extremity motor function in stroke patients and is mainly performed according to functional mobility with a range of motion. This includes lying down, standing, walking, and balance training.
Interventions
It presents the exercise method and amount of exercise for self-exercise and performs self-exercise while receiving feedback from muscle activity during self-exercise.
Eligibility Criteria
You may qualify if:
- years and older
- the onset of the stroke is less than 3months ago
- Lower extremity weakness due to stroke (MMT =\< 4 grade)
- Modified Rankine Scale 2-5 points
- Cognitive ability to follow commands
You may not qualify if:
- stroke recurrence
- other neurological abnormalities (e.g. parkinson's disease).
- severely impaired cognition
- serious and complex medical conditions(e.g. active cancer)
- cardiac pacemaker or other implanted electronic system
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Seoul National University Hospital
Seoul, Jongno, 03080, South Korea
Related Publications (1)
Kim JH, Oh BM, Seo HG, Hyun SE, Han JT, Kang DH, Lee WH. Protocol for a single-blind randomized controlled clinical trial to investigate the feasibility and safety of in-bed self-exercises based on electromyography sensor feedback in patients with subacute stroke. PLoS One. 2024 Dec 30;19(12):e0310178. doi: 10.1371/journal.pone.0310178. eCollection 2024.
PMID: 39775073DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Woo Hyung Lee, prof
Seoul National University Hospital
- STUDY DIRECTOR
Byung-Mo Oh, prof
Seoul National University Hospital
- STUDY DIRECTOR
Han Gil Seo, prof
Seoul National University Hospital
- STUDY DIRECTOR
Sung Eun Hyun, prof
Seoul National University Hospital
- STUDY DIRECTOR
Hye Jung Park, prof
National Traffic Injury Rehabilitation Hospital
- STUDY DIRECTOR
Geun Young Kim, B.S.
National Traffic Injury Rehabilitation Hospital
- STUDY DIRECTOR
Jung Hyun Kim, prof
Seoul National University Hospital
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Masking Details
- An outcome assessor will be blinded after assignment to interventions by blocking access to the web randomization table operated on the website.
- Purpose
- OTHER
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 23, 2023
First Posted
April 20, 2023
Study Start
October 25, 2023
Primary Completion
March 25, 2025
Study Completion (Estimated)
December 1, 2026
Last Updated
June 2, 2025
Record last verified: 2025-05
Data Sharing
- IPD Sharing
- Will not share